Snowball logo
logo
TRVI_logo

Trevi Therapeutics Inc

TRVI NASDAQ
$13.37+$0.18  (1.36%)

Frequently asked questions

What sector does Trevi Therapeutics Inc (TRVI) operate in?

Trevi Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Trevi Therapeutics Inc (TRVI) current stock price?

As of the latest data, Trevi Therapeutics Inc stock price is $13.37, with a previous close of $13.19. Trevi Therapeutics Inc gained $0.18 in the last trading session, representing a 1.36% increase.

What is Trevi Therapeutics Inc (TRVI) current market capitalization?

Trevi Therapeutics Inc market cap is approximately 1.72 billion.

What is Trevi Therapeutics Inc (TRVI) Earnings Per Share (EPS)?

The trailing EPS is -$0.32, and the forward EPS is -$0.57.

What is Trevi Therapeutics Inc (TRVI) EBITDA?

Trevi Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -10.19 million.

Does Trevi Therapeutics Inc (TRVI) pay dividends?

No. Trevi Therapeutics Inc does not pay a dividend.

What is Trevi Therapeutics Inc (TRVI) beta (volatility) score?

Trevi Therapeutics Inc has a beta of 0.990, meaning its volatility is roughly in line with the market.